Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer

被引:9
|
作者
Guan, Alice [1 ]
Shim, Janet K. [2 ]
Allen, Laura [1 ]
Kuo, Mei-Chin [1 ]
Lau, Kathie [1 ]
Loya, Zinnia [1 ]
Brooks, James D. [3 ]
Carroll, Peter R. [4 ]
Cheng, Iona [1 ]
Chung, Benjamin I. [3 ]
DeRouen, Mindy C. [1 ]
Frosch, Dominic L. [5 ]
Golden, Todd [1 ]
Leppert, John T. [3 ]
Lichtensztajn, Daphne Y. [1 ]
Lu, Qian [6 ]
Oh, Debora L. [1 ]
Sieh, Weiva [7 ]
Wadhwa, Michelle [1 ]
Gomez, Scarlett L. [1 ]
Shariff-Marco, Salma [1 ,8 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA
[3] Stanford Univ, Dept Urol, Stanford, CA USA
[4] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
[5] Sutter Hlth Palo Alto Med Fdn Res Inst, Ctr Hlth Syst Res, Palo Alto, CA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX USA
[7] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA
[8] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16 St, San Francisco, CA 94158 USA
来源
CANCER MEDICINE | 2023年 / 12卷 / 05期
基金
美国国家卫生研究院;
关键词
prostate cancer; psychosocial studies; quality of life; translational research; ACTIVE SURVEILLANCE; AFRICAN-AMERICAN; MEN; RACE; SPIRITUALITY; MANAGEMENT; GUIDELINES; RESIDENCE; CARCINOMA; SURVIVORS;
D O I
10.1002/cam4.5405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundFactors that influence prostate cancer treatment decisions are complex, multifaceted, and personal, and may vary by race/ethnicity. Although research has been published to quantify factors involved in decision-making, these studies have been limited to primarily white, and to a lesser extent, Black patients, and quantitative studies are limited for discerning the cultural and contextual processes that shape decision-making. MethodsWe conducted 43 semi-structured interviews with a racially and ethnically diverse sample of patients diagnosed with low- and very-low risk prostate cancer who had undergone treatment for their prostate cancer. Interviews were transcribed, independently coded, and analyzed to identify themes salient for decision-making, with attention to sociocultural differences. ResultsWe found racial and ethnic differences in three areas. First, we found differences in how socialized masculinity influenced patient's feelings about different treatment options. Second, we found that for some men, religion and spirituality alleviated anxiety associated with the active surveillance protocol. Finally, for racially and ethnically minoritized patients, we found descriptions of how historic and social experiences within the healthcare system influenced decision-making. ConclusionsOur study adds to the current literature by expounding on racial and ethnic differences in the multidimensional, nuanced factors related to decision-making. Our findings suggest that factors associated with prostate cancer decision-making can manifest differently across racial and ethnic groups, and provide some guidance for future research.
引用
收藏
页码:6307 / 6317
页数:11
相关论文
共 50 条
  • [41] Factors That Influence Patient Enrollment in Active Surveillance for Low-risk Prostate Cancer
    Gorin, Michael A.
    Soloway, Cynthia T.
    Eldefrawy, Ahmed
    Soloway, Mark S.
    UROLOGY, 2011, 77 (03) : 588 - 591
  • [42] Temporal trends and factors associated with overuse of neoadjuvant androgen deprivation therapy in low and very low risk prostate cancer.
    Delancey, John Oliver
    Matulewicz, Richard
    Schaeffer, Edward M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [43] Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study
    Ho, Tammy
    Howard, Lauren E.
    Vidal, Adriana C.
    Gerber, Leah
    Moreira, Daniel
    McKeever, Madeleine
    Andriole, Gerald
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    CLINICAL CANCER RESEARCH, 2014, 20 (20) : 5331 - 5338
  • [44] VERY-LOW FREQUENCY OF LATEX AND FRUIT ALLERGY IN PATIENTS WITH SPINA-BIFIDA FROM VENEZUELA - INFLUENCE OF SOCIOECONOMIC-FACTORS
    CAPRILESHULETT, A
    SANCHEZBORGES, M
    VONSCANZONI, C
    MEDINA, JR
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1995, 75 (01) : 62 - 64
  • [45] Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions
    Radhakrishnan, Archana
    Wallner, Lauren P.
    Skolarus, Ted A.
    Abrahamse, Paul H.
    Kollipara, Adam S.
    Katz, Steven J.
    Hawley, Sarah T.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (02) : 447 - 454
  • [46] Primary Care Providers’ Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions
    Archana Radhakrishnan
    Lauren P. Wallner
    Ted A. Skolarus
    Paul H. Abrahamse
    Adam S. Kollipara
    Steven J. Katz
    Sarah T. Hawley
    Journal of General Internal Medicine, 2021, 36 : 447 - 454
  • [47] The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer
    Mitchell, Jean M.
    Gresenz, Carole Roan
    MEDICAL CARE, 2022, 60 (09) : 665 - 672
  • [48] Comparison of the Biochemical Recurrence Risk between Radical Prostatectomy and Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
    Martinez, Pablo F.
    Belisle, Diego F.
    Cristallo, Christian
    Tobia, Ignacio
    Damia, Oscar
    Villamil, Wenceslao
    Giudice, Carlos R.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (08): : 655 - 660
  • [49] Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease
    Walser, Eric
    Nance, Anne
    Ynalvez, Leslie
    Yong, Shan
    Aoughsten, Jacqueline S.
    Eyzaguirre, Eduardo J.
    Williams, Stephen B.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (03) : 401 - 409
  • [50] PSA as the driving biomarker to manage low- and intermediate-risk prostate cancer patients in clinical practice
    Ricevuto, Enrico
    Morgani, Celeste
    Seri, Fabrizia
    Bruera, Gemma
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 567 - 568